Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers  Harold S. Nelson, MDa, Kenneth.

Slides:



Advertisements
Similar presentations
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
Advertisements

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.
Occupational asthma caused by a natural food colorant derived from Monascus ruber  Olivier Vandenplas, MDa,b, Jean-Marie Caroyer, MDb, Françoise Binard-van.
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Practice Notes from the AAAI
Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma  Annika Wallin, PhDa, Malcolm Sue-Chu, PhDb, Leif Bjermer,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W
Elephantiasis nostras: A case report
Adverse effects of β-agonists
Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial  William Busse, MDa,
Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.
Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,
Conjunctivitis medicamentosa
Side effects of inhaled corticosteroids
Inhaled corticosteroids: Impact on asthma morbidity and mortality
Practice Notes from the AAAAI
Increased sensitivity to bradykinin among African Americans
Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb 
A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations  John H. Toogood, MD,
A review of the current guidelines for allergic rhinitis and asthma
Physician-targeted program on inhaled therapy for childhood asthma
News & Notes Journal of Allergy and Clinical Immunology
Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype  Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.
James P. Kemp, MDa, David A. Cook, MDb, Gary A
Selective allergic reactions to clavulanic acid
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma  William.
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.
Clinical need for a nebulized corticosteroid
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients.
A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma  Gordon D. Raphael, MDa, Robert.
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma 
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma  Eugene R. Bleecker, MDa, Michael J. Welch, MDb,
Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: A prospective study for 18 months  Wei Qing Wang, MB, Mary Sau Man.
The 30th anniversary of the American Board of Allergy and Immunology: Then and now  Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.
Emma Broadfield, MRCP, Tricia M
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.
The role and remediation of animal allergens in allergic diseases
Renata J. M. Engler, MDa, Julie Kenner, MD, PhDb, Donald Y. M
Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: A nested case-control study  Rolf.
Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective  Helen Donohoe, MSc (Econ) 
Practice Notes from the AAAI
Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes  Stephen Newman, PhDa, Gary Pitcairn, PhDa, Karen Steed,
Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week  Tessa Hodson, BSc, Adnan Custovic, MD, Angela Simpson, MD, Martin.
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma  James P.
Nitric oxide as a clinical guide for asthma management
Anaphylaxis after initial ingestion of rambutan, a tropical fruit
Penicillium nalgiovense as an occupational and contact allergen
Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy  Diane J. Pincus, MD, Teresa R. Humeston,
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Footnotes1 Journal of Allergy and Clinical Immunology
Prescott G. Woodruff, MD, MPH, Ramin Khashayar, MD, Stephen C
Larry C. Borish, MDa, Harold S
The environmental predictors of allergic disease
News & Notes Journal of Allergy and Clinical Immunology
Clinical relevance of inhaled corticosteroids and HPA axis suppression
Presentation transcript:

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers  Harold S. Nelson, MDa, Kenneth R. Chapman, FACPb, Stephen D. Pyke, MScc, Malcolm Johnson, PhDc, John N. Pritchard, PhDc  Journal of Allergy and Clinical Immunology  Volume 112, Issue 1, Pages 29-36 (July 2003) DOI: 10.1067/mai.2003.1558 Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 1 A, Difference in change in mean morning PEF (amPEF) over weeks 1 to 12 between ITT results (fixed-effects model). B, Mean change in clinic FEV1 at week 12 (ITT results). Journal of Allergy and Clinical Immunology 2003 112, 29-36DOI: (10.1067/mai.2003.1558) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 2 A, Odds of achieving a greater than 15 L/min improvement in mean morning PEF (amPEF) with combination therapy compared with concurrent therapy (ITT results). B, Odds of achieving a greater than 30 L/min improvement in morning PEF with combination therapy compared with concurrent therapy (ITT results). Journal of Allergy and Clinical Immunology 2003 112, 29-36DOI: (10.1067/mai.2003.1558) Copyright © 2003 Mosby, Inc. Terms and Conditions

Fig. 3 Raman laser analysis of Seretide metered-dose inhaler formulation on stage 4 of an Anderson Cascade Impactor showing particles of fluticasone propionate (green) , salmeterol (red) , and coassociation of both fluticasone propionate and salmeterol (yellow) . Journal of Allergy and Clinical Immunology 2003 112, 29-36DOI: (10.1067/mai.2003.1558) Copyright © 2003 Mosby, Inc. Terms and Conditions